Edible mushroom agent and staple food grain prebiotics for treating diabetes and improving immunity and production technology of edible fungus agent and staple food grain prebiotics

Abstract

The invention relates to formulas of main materials, auxiliary materials and seasonings of a staple food grain prebiotic culture medium which is also called Tianfu TNB, edible fungi and fermentation equipment. The staple food grains comprise rice, corn and soybeans. The edible fungi are family-borne edible microbial flora (FEMF) and improved auxiliary bacteria thereof, the flora structure, the strain of the improved FEMF flora and the structure and proportion of the auxiliary flora are clarified, and the microbial agent presents a sour and sweet taste after being fermented. The fermentation technology has 1-5 grades, and the product technology comprises liquid state and solid state. In order to facilitate fermentation, simple fermentation equipment capable of rotating by 360 degrees is designed and manufactured. After eating the product for 17 days, young and middle-aged people have stable and normal blood glucose; a 83-year-old diabetic patient who is always dizzy and has cardiac pain is basically cured and the immunocompetence is improved after 3 months; and for a patient with long-term family inherited long-term type II diabetes mellitus, who is injected with insulin, takes western medicines and has blood glucose of 14.2 during empty stomach, blood glucose is normal after 28 days of adjuvant therapy, and gastritis and urinary system diseases are both improved.

Description

technical field [0001] The invention relates to a functional microbial agent for treating metabolic syndrome such as diabetes, gastrointestinal chronic diseases and discomfort (can relieve alcohol), and improving immunity, a nutritional staple food prebiotic containing plant secondary metabolites and its production technology, which belongs to the application Biotechnology forms therapeutic functional food, which can treat diabetes, improve blood sugar status and improve immunity of patients, and is convenient, safe and reliable. Background technique [0002] At present, metabolic syndrome such as diabetes has become an increasingly serious disease that affects public health in the world. Metabolic syndrome includes diabetes, hyperglycemia, hyperuric acid, and hyperlipidemia. However, it is actually difficult to use traditional Chinese medicine for lowering blood sugar. Traditional clinical treatment of diabetes is mainly based on oral hypoglycemic drugs, insulin injections ...

AI Technical Summary

Problems solved by technology

[0002] At present, metabolic syndrome such as diabetes has become an increasingly serious disease affecting public health in the world. Metabolic syndrome includes diabetes, hyperglycemia, hyperuric acid, and hyperlipidemia. However, it is actually difficult to use traditional Chinese medicine for lowering blood sugar

Traditional clinical treatment of diabetes is mainly based on oral hypoglycemic drugs, insulin injections and lifestyle intervention (diet, exercise). From the perspective of scientific research, the clinical detection and analysis of modern diseases is still limited to single-gene genetic diseases or chromosomal diseases, such as Type 2 diabetes is a complex disease that is related to many aspects such as genetics, environment, and diet. There is no conventional molecular detection and analysis method for the time being, and research and analysis tend to be carried out from the perspectives of intestinal flora, metabolism, and small molecules.

Images